Our mission is to fast-track rare cancer therapy discovery and stem cell therapies wide adoption and ready-availability to patients. We do this by making available on a large scale and economically rare cancer cells and stem cells that remain physiologically relevant without the chemical modification resulting in cell alteration that all other present-market technologies offer.